Abstract
Lysosomes are ubiquitous, acidic intracellular compartments that fulfil a crucial role in degradation of macromolecules in cells. Specific lysosomal catabolic reactions may be impaired due to inherited defects in specific hydrolases, resulting in gradual intralysosomal accumulation of corresponding endogenous substrates. Such lysosomal deficiencies may ultimately result in devastating clinical symptoms, the so-called lysosomal storage diseases. Many of the inherited lysosomal storage disorders show phenotypic variants in which neurological complications are prominent as the result of pathological storage formation in cells inside the brain, for example perivascular macrophages, microglia or neuronal cells. In this chapter new developments and present limitations regarding therapy of (neuronopathic) lysosomal storage diseases are reviewed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
